60
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
544527
SYNformulas is a research-driven probiotics company active in the field of gastrointestinal diseases and allergies.
David Rietbrock: Chief Executive OfficerPast Role: McKinsey & Company, Associate Partner
About the Company
SYNformulas is one of the world's leading research-driven probiotics companies active in the field of gastrointestinal diseases and allergies. In cooperation with internationally recognized researchers and universities, the medium-sized company translates the latest scientific findings from microbiome research into visionary products. The
innovative and evidence-based therapy options are marketed throughout Europe under the umbrella brand Kijimea.
The acclaimed scientific standards, the high quality and stability of Kijimea products help SYNformulas to achieve its international status as a global leader in probiotics.
